CEDAR FALLS, Iowa – September 15, 2026 – On The Pen, an independent GLP-1 news and media platform covering obesity medicine, diabetes, metabolic health and the pharmaceutical industry, has launched a redesigned version of OnThePen.com.
The refresh gives On The Pen a cleaner, more traditional digital newsroom with improved navigation, stronger breaking-news presentation and easier access to written reporting, podcasts, livestreams and video coverage.
The redesigned site expands On The Pen’s role as a destination for top-ranked GLP-1 news, including coverage of Ozempic, Wegovy, Mounjaro, Zepbound, retatrutide, clinical trials, drug pricing, access, insurance, telehealth, compounding and pharmaceutical industry developments.
“On The Pen started because there was a deficit of information that actually spoke to them,” said founder Dave Knapp. “The new site gives that reporting a stronger home and makes it easier for people to understand what is happening in GLP-1 medicine and what it could mean for them.”
The website also gives greater prominence to On The Pen: The Weekly Dose Podcast, a top-ranked, award-winning GLP-1 podcast in the top 0.5% of all podcasts globally.
Together, the website, podcast and live programming position On The Pen as an independent multimedia source for GLP-1 news, obesity medicine coverage and patient-centered reporting.
About On The Pen
On The Pen is an independent GLP-1 news and media platform covering GLP-1 medications, obesity medicine, diabetes, metabolic health and the pharmaceutical industry. The platform publishes breaking GLP-1 news, original reporting, analysis, livestreams and On The Pen: The Weekly Dose Podcast. Its mission is to empower patients to have better conversations with their doctors.
Media ContactCompany Name: OTP MEDIA CORPContact Person: Ann.MetzEmail: Send EmailPhone: 3193000840Address:3045 Capital Way #5 Stge 201-GCity: Cedar FallsState: IACountry: United StatesWebsite: www.onthepen.com
